Jonathan Ruditser

About Jonathan Ruditser

As a licensed clinical pharmacist and entrepreneurial leader, I bring a unique blend of clinical insight and commercial acumen to drive innovation across the pharmaceutical and healthcare landscape. With a proven track record of building and scaling strategic initiatives, I thrive at the intersection of patient care, business development, and healthcare transformation.Currently serving as Director of Pharmacy Channel Solutions for both the Immunology and Pulmonary Hypertension portfolios at Johnson & Johnson, I lead enterprise-level strategies that enhance patient access, streamline operations, and deliver measurable impact. My career is comprised of leadership roles across various verticals of the healthcare and pharmaceutical industries, where I\'ve built new service lines, drove revenue growth, and executed go-to-market strategies. Through each step of my career journey, I continue to shape industry dialogue and share forward-thinking insights with global stakeholders.An entrepreneur at heart, I’ve consistently identified market gaps and turned them into opportunities—spearheading growth strategies, forging high-value partnerships, and guiding cross-functional teams with a vision-first mindset. With a Doctor of Pharmacy (PharmD) degree from Massachusetts College of Pharmacy and Health Sciences, I am committed to advancing healthcare through innovation, agility, and purpose-driven leadership.

Experience

1. Senior Pharmaceutical Consultant

   GLG

   Jan 2015 — Present · New York, NY, US

   Advisor to Financial Firms | Pharmaceutical Industry Expertise | Strategic Guidance on Investments & Market Trends I lead consulting opportunities by providing strategic advisory services to financial firms, leveraging deep expertise in the pharmaceutical industry to identify and evaluate investment opportunities. Key contributions include:Targeted Guidance: Collaborate with financial institutions to analyze financial models, assess market access trends, and identify high-value acquisition and licensing targets.Industry Insights: Deliver actionable insights into provider, pharmacy partner, and reimbursement barriers to navigate evolving market dynamics.Scientific Communication: Present complex scientific data to diverse audiences, enabling fact-based, strategic decision-making.Strategic Reviews: Evaluate business cases and serve as a clinical and operational resource during committee meetings, ensuring informed investment strategies.